BiotechBrandon

MITC Readying for a Recovery?

Viés de alta
NASDAQ:MITC   None
Its been a brutal year for Nasdaq, and $MITC is no exception. Its been tracking downwards since December after the Black Friday dip in major US indexes. While $MITC has underperformed $NDX, its smaller enterprise value makes this equity more vulnerable to background volatility, and the fact that the MITC and NDX price action's have followed the same course indicates a tight nexus. That said, we may be in for a reversal soon, and the fact that $MITC's RSI is in undervalued territory speaks to this. MACD is also moving in a positive direction, so I for one am banking on the fact that once NASDAQ reestablishes its foot, $MITC will be right up there with it.

Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.